Merck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab
Merck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Added Stage III Trials of Avelumab “We have observed encouraging signs of early scientific activity of avelumab in patients with … Accessed November 2015. 4. National Cancer Institute. Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQSee Original Article MULU/Worksite Medical Network […]